Cardlytics (NASDAQ:CDLX) CEO Amit Gupta Sells 62,549 Shares of Stock

Key Points

• CEO Amit Gupta sold 62,549 shares on April 1 at an average price of $0.99 (proceeds ~$61,924), and has executed multiple insider sales since January totaling 219,789 shares, leaving him with 1,111,445 shares (a 5.33% ownership decline).
• Stock popped 13.0% to $1.13 on heavy volume (2,137,597 shares vs. a 1,043,434 average), valuing Cardlytics at about $62.2 million.
• Company fundamentals remain weak: Cardlytics missed EPS expectations (reported -$0.15 vs. -$0.07), shows a -44.36% net margin and -370.98% ROE, and carries a consensus analyst rating of "Reduce" with a $1.75 target.

Cardlytics, Inc. (NASDAQ:CDLX - Get Free Report) CEO Amit Gupta sold 62,549 shares of the firm's stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $0.99, for a total transaction of $61,923.51. Following the sale, the chief executive officer owned 1,111,445 shares of the company's stock, valued at approximately $1,100,330.55. This represents a 5.33% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

Amit Gupta also recently made the following trade(s):

• On Thursday, April 2nd, Amit Gupta sold 54,225 shares of Cardlytics stock. The shares were sold at an average price of $1.04, for a total transaction of $56,394.00.
• On Wednesday, February 18th, Amit Gupta sold 45,159 shares of Cardlytics stock. The stock was sold at an average price of $0.93, for a total transaction of $41,997.87.
• On Tuesday, February 17th, Amit Gupta sold 52,049 shares of Cardlytics stock. The shares were sold at an average price of $0.90, for a total transaction of $46,844.10.
• On Monday, January 5th, Amit Gupta sold 5,807 shares of Cardlytics stock. The shares were sold at an average price of $1.17, for a total transaction of $6,794.19.

Cardlytics Stock Up 13.0%

Shares of CDLX traded up $0.13 during midday trading on Thursday, reaching $1.13. 2,137,597 shares of the stock were exchanged, compared to its average volume of 1,043,434. The company has a market cap of $62.23 million, a price-to-earnings ratio of -0.58 and a beta of 0.91. Cardlytics, Inc. has a 12-month low of $0.66 and a 12-month high of $3.28. The firm has a 50 day simple moving average of $0.90 and a 200-day simple moving average of $1.34.

Cardlytics (NASDAQ:CDLX - Get Free Report) last posted its earnings results on Wednesday, March 4th. The company reported ($0.15) earnings per share for the quarter, missing the consensus estimate of ($0.07) by ($0.08). The company had revenue of $56.10 million for the quarter, compared to the consensus estimate of $54.46 million. Cardlytics had a negative net margin of 44.36% and a negative return on equity of 370.98%. Research analysts expect that Cardlytics, Inc. will post -1.52 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in CDLX. Vanguard Personalized Indexing Management LLC bought a new stake in shares of Cardlytics in the third quarter valued at approximately $26,000. Sand Hill Global Advisors LLC bought a new position in Cardlytics during the second quarter worth $35,000. Virtu Financial LLC bought a new position in Cardlytics during the fourth quarter worth $39,000. Qube Research & Technologies Ltd acquired a new position in Cardlytics during the 3rd quarter valued at $55,000. Finally, Marshall Wace LLP bought a new stake in Cardlytics in the 2nd quarter valued at $59,000. 68.10% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities analysts have commented on CDLX shares. Bank of America reiterated an "underperform" rating on shares of Cardlytics in a report on Thursday, March 5th. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Cardlytics in a report on Monday, December 29th. Finally, Evercore set a $1.00 target price on shares of Cardlytics in a research note on Friday, March 6th. Two investment analysts have rated the stock with a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Reduce" and a consensus target price of $1.75.

About Cardlytics

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers' online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.

At the core of Cardlytics' offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.